GH Research
GH Research plc is a clinical-stage biopharmaceutical company focused on developing innovative treatments to achieve ultra-rapid, durable remission for depression and transform care for psychiatric and neurological disorders.
About GH Research
GH Research is a biopharma startup founded in 2018 with a mission to transform the treatment of psychiatric and neurological disorders. Established to address significant unmet needs in mental and brain health, the company focuses on developing innovative therapies based on advanced scientific research and clinical development. Since its founding, GH Research has worked to push the boundaries of neuropsychiatric treatment, aiming to deliver more effective and meaningful solutions for patients suffering from complex and often debilitating conditions.



